Pathogenics, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.25
from 8-K 3 pages Schedule a Release
12/34/56
EX-10.21
from 10KSB 2 pages Amendment No. 2 to License Agreement
12/34/56
EX-10.20
from 10KSB 2 pages First Amendment to Consultancy Agreement
12/34/56
EX-10.19
from 10KSB 5 pages Second Amendment to Employment Agreement
12/34/56
EX-10.18
from 10KSB 2 pages Amendment No. 1 to License Agreement
12/34/56
EX-10.17
from 10KSB 21 pages License Agreement
12/34/56
EX-10.16
from 10KSB 15 pages License Agreement
12/34/56
EX-10.15
from 10KSB 3 pages Revocation of Assignment
12/34/56
EX-10.13
from 10KSB ~1 page This Letter Is to Confirm Our Mutual Agreement and Understanding With Respect to the Role of Qualified Ventures, LLC ("Qv") as a Consultant in Connection With the Potential Merger, Asset Purchase, Licensing Agreement or Similar Business Combination (The "Transaction") Between Pathogenics, Inc. ("Pathogenics") and Acuity Pharmaceuticals, Inc. ("Partner")
12/34/56
EX-10.12
from 10KSB 5 pages Consultancy Agreement
12/34/56
EX-10.11
from 10KSB 5 pages First Amendment to Employment Agreement
12/34/56
EX-10.10
from SB-2/A ~10 pages Consultancy Agreement
12/34/56
EX-10.9
from SB-2/A 1 page Assignment Agreement
12/34/56
EX-10.8
from SB-2/A ~20 pages Exclusive License Agreement
12/34/56
EX-10.7
from SB-2 ~10 pages Material contract
12/34/56
EX-10.6
from SB-2 ~5 pages Material contract
12/34/56
EX-10.5
from SB-2 ~5 pages Material contract
12/34/56
EX-10.4
from SB-2 1 page Material contract
12/34/56
EX-10.3
from SB-2 ~5 pages Material contract
12/34/56
EX-10.2
from SB-2 ~10 pages Material contract
12/34/56